Introduction
In addition to the well-established role of GABA in conventional, phasic synaptic inhibition, this neurotransmitter also participates in a tonic form of inhibition (Mody and Pearce, 2004; Farrant and Nusser, 2005) . Tonic inhibition arises from constant activation of GABA A receptors and has been studied most extensively in cerebellar granule cells, where it is the predominant form of inhibition (Kaneda et al., 1995; Brickley et al., 1996 Brickley et al., , 2001 Hamann et al., 2002; Rossi et al., 2003) and has been proposed to arise at least partially from channel-mediated release of GABA from glia (Lee et al., 2010) . Although tonic inhibition has been studied mainly in slices, it is not a consequence of the slicing procedure because it has been observed in vivo in both cerebellar (Chadderton et al., 2004) and olfactory (Labarrera et al., 2013) granule cells. Tonic inhibition controls the gain and excitability of cerebellar granule cells (Mitchell and Silver, 2003) , and at least some of the behav-ioral effects of ethanol consumption may arise from augmentation of tonic inhibition (Wallner et al., 2003; Hanchar et al., 2005) .
Our current understanding of tonic inhibition is largely based on electrophysiological measurements of GABA-induced chloride currents. While such measurements offer very high sensitivity, they provide minimal spatial information. Thus, although it is clear that currents produced by tonic inhibition can be detected from recordings from the cell bodies of several types of neurons, it is rarely known which cellular compartments actually receive tonic inhibition. Here we use Clomeleon, an optogenetic fluorescent chloride indicator , to image the spatial extent of tonic inhibition of cerebellar granule cells. We have taken advantage of transgenic mice that express Clomeleon in various subsets of neurons ; these mice have enabled imaging of local changes in intracellular chloride concentration ([Cl Ϫ ] i ) associated with phasic synaptic inhibition , heterogeneity of [Cl Ϫ ] i and GABA responses in different compartments of retinal neurons (Duebel et al., 2006) , and [Cl Ϫ ] i increases in hippocampal neurons associated with both ischemia (Pond et al., 2006) and seizure activity (Glykys et al., 2009; Dzhala et al., 2010 Dzhala et al., , 2012 Lillis et al., 2012; Glykys et al., 2014) .
Our results follow-up on a preliminary report indicating that Clomeleon imaging allows visualization of tonic inhibition (Lee et al., 2010) and demonstrate that tonic inhibition approximately doubles resting [Cl Ϫ ] i in cerebellar granule cells. Remarkably, tonic inhibition occurs not only on granule cell bodies (GCBs) and dendrites, but also on their axons, the parallel fibers (PFs). Tonic inhibition of PFs was observed in vivo and reduces both spontaneous and evoked release of glutamate from PF presynaptic terminals. Thus, presynaptic tonic inhibition may serve as an important regulator of information flow through the synaptic circuits of the cerebellar cortex. Given that somatic tonic inhibition is found throughout the brain, presynaptic tonic inhibition may also be a general mechanism for regulating neurotransmitter release during phasic synaptic transmission.
Materials and Methods
Immunohistochemistry. Immunohistochemistry was used to determine the pattern of Clomeleon expression in the cerebellum. In brief, anesthetized CLM1 transgenic mice ; The Jackson Laboratory, RRID: IMSR_JAX:013161) were transcardially perfused with phosphatebuffered saline (PBS) containing (in mM) as follows: 137 NaCl, 2.7 KCl, 10 NaH 2 PO 4 , and 1.8 KH 2 PO 4 (pH 7.4 with HCl), then with a PBS solution containing 4% paraformaldehyde (PFA). Brain tissue was then removed and postfixed overnight in 4% PFA solution at 4°C. For subsequent cryoprotection, tissue was kept overnight in PBS solutions containing graded concentrations of sucrose ranging from 10%-30% (w/v). A freezing microtome (CM 3050S, Leica) was used to cut the brain, including cerebellum, into 20-m-thick parasagittal sections. Sections were initially washed in 0.1 M PBS followed by blocking buffer (2% normal goat serum and 0.1% Triton X-100), and then incubated with anti-metabotropic glutamate receptor 2 (mGluR2) rabbit primary antibody (1:250, Abcam) and anti-YFP chicken primary antibody (1:1000, Abcam) for 48 h at 4°C. Sections were then further incubated with anti-rabbit Alexa-594 (1:500, Invitrogen) and anti-chicken Alexa-488 (1:500, Invitrogen) secondary antibodies. These incubations were performed at room temperature in the blocking buffer, followed by a rinse with PBS. Finally, sections were mounted with antifade reagent (ProLong Gold, Invitrogen) and coverslipped for confocal imaging. To identify the cell bodies of molecular layer (ML) interneurons, a subset of brain sections were immunostained with the anti-YFP primary antibody, followed by anti-chicken Alexa-488 secondary antibody and then stained with DAPI (Invitrogen).
Slice preparation. Cerebellar slices were prepared, using conventional methods (Tanaka et al., 2007) , from 2-to 8-week-old homozygous CLM1 mice of either sex. In brief, the mice were anesthetized, and their brains were isolated and then placed in cold artificial cerebrospinal fluid (ACSF), containing the following (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 20 D(ϩ)-glucose, 2 CaCl 2 , and 1.3 MgCl 2 (pH 7.4 after bubbling with 95% O 2 /5% CO 2 , v/v). A vibratome was used to make 200-m-thick slices; usually these were cut in the sagittal plane. The slices were then incubated at 36°C for 30 min before use.
Microscopy. Most Clomeleon imaging was done with a wide-field fluorescent microscope, as described by Berglund et al. (2006) . For this purpose, an upright epifluorescence microscope (E600-FN, Nikon) was equipped with a 10 ϫ 0.3 NA objective for the Clomeleon imaging experiments or with a 40 ϫ 0.8 NA water-immersion objective for the electrophysiological experiments. This microscope included in its excitation pathway a mercury arc lamp, an electronic shutter (Uniblitz), an excitation filter (440 Ϯ 10 nm), and a dichroic mirror (460 nm); the emission pathway included a filter wheel (Ludl Electronic Products) that alternated between two emission filters (485 Ϯ 15 nm for CFP and 530 Ϯ 15 nm for YFP; 71007a Cameleons 2, Chroma). Fluorescence excitation was produced by light pulses (200 -500 duration, 0.5 Hz), and fluorescence emission was alternately collected at each wavelength with a backilluminated, cooled CCD camera with on-chip multiplication gain control (Cascade 512B, Photometrics). Image acquisition was controlled by RatioTool software (ISee Imaging Systems) and a PowerMac G4 (Apple Computer). Further details of the imaging system can be found in Berglund et al. (2006) .
To measure Clomeleon fluorescence in the granule cell and MLs, two ROIs covering these layers were defined. The intensity of YFP fluorescence, corrected for detector dark current and other sources of background signal, was divided by that of CFP to calculate a ratio in each ROI that is inversely proportional to [Cl Ϫ ] . Autofluorescence accounted for Ͻ1.5% of the total fluorescence and did not have any significant effect on the calculated ratio (Pond et al., 2006) . Photobleaching (Berglund et al., 2005; Friedel et al., 2013) was minimized by using a low level of excitation light, with neutral density filters used to attenuate excitation light from the mercury lamp Ͼ500-fold. Because of the low levels of fluorescence emission under these conditions, pixels on the CCD camera chip were sometimes binned by a factor of 2 to increase signal/noise. If any obvious trend due to photobleaching remained, it was corrected by fitting a regression line or an exponential function to traces measured in the absence of responses.
For experiments where GABA or GABA receptor antagonists were locally applied (see Figs. 7, 8) , images were produced by averaging raw images over 3 or 4 trials and smoothed by a Gaussian filter (20 m) twice before calculating the fluorescence emission ratio. Such ratio images were then converted into [Cl Ϫ ]. All the image processing, analysis, and statistical tests were done by IgorPro 6.1 (WaveMetrics).
The measurements shown in Figures 2, 6 , and 10 were done with 2-photon imaging, using either an Ultima IV microscope (Prairie Technologies) or an Olympus FV1000 microscope. Clomeleon was excited using 860 nm excitation light and either a 25 ϫ or 40 ϫ water-immersion objective (Olympus) with total output power Ͻ50 mW. A fluorescence filter cube with an emission beamsplitter (71007, Chroma) was used for fluorescence emission. During imaging, 512 ϫ 512 pixel images were acquired continuously every 30 s, with 4 images averaged to yield the results shown.
Calibration of Clomeleon. The Clomeleon fluorescence emission ratio (YFP/CFP) was converted into [Cl Ϫ ] i as detailed by Kuner and Augustine (2000) and Berglund et al. (2009) . In brief, [Cl Ϫ ] i was calculated based on the following equation: 
Measurement of intracellular pH.
A stock solution of SNARF-5F AM ester (2 mM; Invitrogen) in Pluronic F-127 (20% w/v solution in DMSO; Invitrogen) was added to an oxygenated ACSF at a final concentration of 4 -20 M. After incubation at 36°C, cerebellar slices from C57BL/6 wildtype mice were exposed to the SNARF-5F AM solution for 30 -60 min and washed in oxygenated ACSF for at least 15 min at room temperature. Slices loaded with SNARF-5F were then imaged as described above, except for an excitation filter (540.5 Ϯ 12.5 nm), a dichroic mirror (565 nm cutoff), and emission filters (580 Ϯ 12.5 and 630 Ϯ 30 nm). SNARF-5F emission ratio (630/580) was calibrated in vitro, as described previously (Pond et al., 2006) , by using the following equation:
where R is the measured 630/580 nm emission ratio, R min and R max represent the values when SNARF-5F is either H ϩ bound or H ϩ free, respectively, and K d is the effective H ϩ dissociation constant of SNARF-5F.
The K d of Clomeleon was then corrected for measured pH changes by using the following equation:
where K d is Cl Ϫ dissociation constant of Clomeleon obtained at pH 7.10 described above and K d Ј is pH-corrected Cl Ϫ dissociation constant at any given pH (pHЈ) measured by SNARF-5F. In vivo imaging. Clomeleon transgenic mice (age 5-10 weeks) initially were anesthetized with intraperitoneal injection of ketamine (100 mg/ kg) and xylazine (10 mg/kg). Their heads were shaved and the mice were then placed in a stereotaxic head frame. Isoflurane gas (2%) in oxygen was administered throughout the experiments, and the electrocardiogram was measured continuously to monitor the physiological status of the mice. Body temperature was measured by a rectal probe and maintained at 38°C by a feedback-controlled heating pad. Before making an incision, droplets of bupivacaine were applied subcutaneously. A wire mesh was attached to the skull with acrylic glue to provide an anchor point for dental acrylic resin, and a stainless steel head plate with a 2 mm opening was cemented above the craniotomy site. A craniotomy was performed above the cerebellum, and the dura was removed.
The GABA A receptor blocker SR95531 (SR; also called gabazine; Tocris Bioscience) was administered either by topical application onto the surface of the cerebellum or via subcutaneous injection. For topical application, polyethylene tubing was filled with SR solution (2 mM in sterilized normal saline [0.9% w/v NaCl]) via suction and then connected to a Hamilton syringe in an injection pump. The tip of the tubing was filled with SR-free saline, which served as a control, and was placed at the edge of the craniotomical window. The time when solution switched between control and SR solutions (see Fig. 6E , F, horizontal bars) was determined in advance by filling the same tubing with a fluorescent dye solution of the same volume in the same manner. Alternatively, SR was administered by subcutaneous injection at a dose of 5 mg/kg body weight.
Regardless of the method of drug application, the imaging window was sealed with a glass coverslip (diameter: 5 mm; thickness: #1; Warner Instruments) and low-melting point agar (2%) in normal saline. The objective lens was immersed in a droplet of normal saline on the coverslip. After completing the surgical procedures, isoflurane concentration was lowered to 0.5%-1% to maintain anesthesia during in vivo imaging.
Because solution exchange was practically impossible during in vivo experiments, the Clomeleon ratio was calibrated on the 2-photon microscope by using slices maintained at 38°C by a temperature controller (TC-344B, Warner Instruments). Although we were able to match the temperature, one of the critical determinants of Cl Ϫ binding to Clomeleon (Berglund et al., 2009) Electrophysiology. Conventional whole-cell patch-clamp recordings were obtained from Purkinje cells by an Axopatch 1D amplifier (Molecular Devices), as described previously (Tanaka et al., 2007) . Pipettes (4 -5 M⍀) were filled with a solution that contained (in mM) the following: 130 K-gluconate, 2 NaCl, 0.5 EGTA, 20 HEPES, 4 Na 2 -ATP, 0.4 Na 3 -GTP, 4 MgCl 2 . pH was adjusted to 7.2 with KOH. The cells were voltage clamped at E Cl (approximately Ϫ70 mV) to isolate EPSCs.
The chamber was constantly superfused with oxygenated ACSF at 2 ml/min. Most experiments were done at room temperature (ϳ24°C); in some cases, the slice was maintained at 34°C by an electronic temperature controller. ACSF containing SR (10 M), TTX (Tocris Bioscience; 1 M), bicuculline (Sigma; 20 M), furosemide (Tocris Bioscience; 100 M), GABA (Sigma; 10 nM-100 M), CGP55845 (Tocris Bioscience; 2 or 50 M), or acetazolamide (Sigma; 50 M) was bath applied by diluting a stock solution into the ACSF before chamber superfusion. In the Ca 2ϩ -free ACSF solution, CaCl 2 was replaced by an equimolar concentration of MgCl 2 , and EGTA (2 mM) was added to chelate remaining trace amounts of Ca 2ϩ . Following a solution change, measurements were made after reaching an apparent steady state. For the experiments shown in Figure  10C , there was a systematic shift in baseline [Cl Ϫ ] i ; to measure responses to SR, this shift was subtracted by fitting a single exponential while masking the time of drug application.
To stimulate PFs, a glass electrode (tip diameter ϳ10 m) was used. This electrode was positioned in the ML near the Purkinje cell body and electrical stimuli (5-10 A, 100 -200 s duration) were applied by a stimulator (S44, Grass Instruments) with a stimulus isolation unit (PSIU6, Grass Instruments). When examining synaptic facilitation with paired stimulation, stimulus pairs were repeated every 10 s.
Animal experiments. All animal procedures listed here were approved by the Duke University Animal Care and Use Committee or by the Institutional Animal Care and Use Committee of the Biopolis Biological Resource Center in Singapore.
Experimental measurements are expressed as mean Ϯ SEM, unless indicated otherwise.
Results

Clomeleon expression in cerebellar granule cells
The CLM1 line reportedly expresses the optogenetic Cl Ϫ indicator, Clomeleon, in cerebellar granule cells . In slices prepared from these mice, the cerebellar granule cell layer (GCL) was highly fluorescent and the molecular layer (ML) was more diffusely fluorescent, whereas no fluorescence was observed in the Purkinje cell layer (PCL) (Fig. 1A ). This pattern of expression is consistent with Clomeleon being expressed in GCBs and dendrites (to yield fluorescence in the GCL) as well as in their axons, the PFs, within the ML.
To more precisely determine which cells express Clomeleon, we examined the spatial pattern of fluorescence within the cerebellum at higher magnification. Within the GCL, Clomeleon fluorescence appeared to be restricted to a dense population of neurons with small cell bodies (3-5 m diameter), characteristic of granule cells (Fig. 1B, top) . Occasional gaps in fluorescence apparently were caused by Golgi cells: labeling of Golgi cells, via an mGluR2 antibody (Fig. 1B, center) , revealed that the nonfluo-rescent areas corresponded to Golgi cell bodies (Fig. 1B, bottom ). More generally, there was minimal spatial overlap between the fluorescence signals from Clomeleon and mGluR2, indicating a lack of Clomeleon expression in Golgi cells. Similarly, within the ML, the diffuse pattern of Clomeleon fluorescence was associated with structures too small to be resolved (Fig. 1C, top) , consistent with localization to sagitally sectioned PFs (which have a crosssectional diameter of Ͻ1 m). Clomeleon fluorescence was excluded from blood vessels as well as small spherical regions ϳ10 m in diameter. The spherical regions contained nuclei, as indicated by the nuclear label, DAPI (Fig. 1C, center) . There was no overlap between Clomeleon and DAPI labeling within the ML (Fig. 1C, bottom) ; given that interneurons are the predominant cell type within the ML, we conclude that interneurons, both within the ML as well as the GCL, do not express Clomeleon. In summary, our results extend previous indications that granule cells are the only cells expressing Clomeleon within the cerebellar cortex of this mouse line , allowing us to use this mouse to image [Cl Ϫ ] i in granule cells.
Imaging tonic inhibition with Clomeleon
By measuring the ratio of fluorescence emission of the CFP donor and YFP acceptor of Clomeleon, we could determine resting [Cl Ϫ ] i in both the GCBs within the GCL and their PFs within the ML (Fig. 2 A, B) . When measured at room temperature (24°C), resting [Cl Ϫ ] i was in the range of 5-10 mM in both compartments (Fig. 2C ). On average, resting [Cl Ϫ ] i was slightly higher in PFs than in GCBs (two-tailed paired Student's t test; t (23) ϭ 2.093; p ϭ 0.048; n ϭ 24). From these values, we calculated the equilibrium 
potential for Cl
Ϫ (E Cl ) to be Ϫ74 mV for GCBs and Ϫ65 mV for PFs. Thus, there is a substantial difference in E Cl between GCBs and PFs. Very similar results were obtained when the measurements were repeated at a more physiological temperature (34°C; Fig. 2D ): resting [Cl Ϫ ] i was significantly higher in PFs than in GCBs (two-tailed Wilcoxon paired-sample test; p ϭ 0.016; n ϭ 7).
Clomeleon also allowed us to image chloride-based inhibition of these cells. To visualize tonic inhibition caused by ambient GABA, we treated cerebellar slices with GABA A receptor antagonists; in most experiments, we applied SR95531 (SR; also called gabazine; 10 M), although occasionally we instead applied bicuculline (20 M). Treatment with either antagonist reduced basal [Cl Ϫ ] i substantially (Fig. 3A) , as expected if these drugs were blocking a constant Cl Ϫ influx produced by tonic inhibition. Thus, Clomeleon imaging is capable of reporting the magnitude, time course, and spatial distribution of rises in [Cl Ϫ ] i produced by tonic inhibition.
The image shown in Figure 3A indicates that SR caused a reduction in [Cl Ϫ ] i both in the GCL, where the cell bodies and dendrites of the granule cells reside, as well as in the ML, where PF axons are the only Clomeleon-expressing structures. These reductions in [Cl Ϫ ] i were relatively rapid, reaching a peak within 1-2 min both in GCBs (Fig. 3B ) and in PFs (Fig. 3C) , and reversed promptly upon removal of the SR. This time course presumably reflects the competitive interaction between SR and ambient GABA, as well as the rate of drug addition/removal. At 24°C, the SR-induced decrease in [Cl Ϫ ] i was ϳ5 mM and was very similar in magnitude in GCBs and PFs ( Fig. 3D; Pond et al., 2006) . We therefore measured intracellular pH in granule cells loaded with a pH indicator, SNARF-5F (Fig. 4A) . The basal pH of GCBs and PFs was 7.15 Ϯ 0.01 and 7.11 Ϯ 0.02 (mean Ϯ SEM; n ϭ 12), respectively, which were statistically different (two-tailed Wilcoxon pairedsample test; p ϭ 0.042; n ϭ 12). During application of SR, pH in both compartments increased by 0.04 (Fig. 4 B, . We therefore conclude that tonic inhibition actually elevates [Cl Ϫ ] i in addition to slightly acidifying pH.
Properties of tonic inhibition of presynaptic PFs
The remainder of our study largely focused on tonic inhibition of PFs, which presumably went undetected in previous electrophysiological measurements from GCBs. We next asked whether the properties of presynaptic tonic inhibition of PFs, as reported by Clomeleon imaging, are comparable with those identified for tonic inhibition of postsynaptic GCBs. For this purpose, we performed several pharmacological experiments that addressed the sources of GABA in the ML and the identity of the GABA A receptors mediating the response of PFs to this GABA.
Tonic inhibition of cerebellar GCBs is mediated by ambient release of GABA that does not require electrical activity in presynaptic neurons (Rossi et al., 2003) . To determine whether tonic inhibition of PFs exhibits similar characteristics, we examined the effects of TTX. Unlike bicuculline or SR, TTX (1 M) had no significant effect on basal [Cl Ϫ ] i (Fig. 5A) ; TTX produced a reduction of 0.5 Ϯ 0.4 mM (mean Ϯ SEM; n ϭ 6) in basal [Cl Ϫ ] i , providing an indication that tonic inhibition of PFs does not require neuronal activity. More importantly, bicuculline (20 M) still blocked tonic inhibition in the presence of TTX; the changes in [Cl Ϫ ] i produced by bicuculline were similar (two-tailed Wilcoxon paired-sample test; p ϭ 0.22; n ϭ 6) in the absence or presence of TTX (Fig. 5 A, B ). This provides a second indication that tonic inhibition of PFs does not require neuronal activity. Similar results were observed in GCBs as well; bicuculline decreased [Cl Ϫ ] i similarly in the absence or presence of TTX (2.1 Ϯ 0.5 mM vs 1.7 Ϯ 0.4 mM; mean Ϯ SEM; n ϭ 6; two-tailed Wilcoxon paired-sample test; p ϭ 0.22), yielding one further indication that tonic inhibition of granule cells does not require neuronal activity.
Tonic inhibition of cerebellar GCBs also does not require Ca 2ϩ -dependent exocytosis (Rossi et al., 2003 (Fig. 5C ), although, as expected, the effect of SR was significantly smaller in Ca 2ϩ -free solution than in control conditions ( Fig. 5D ; two-tailed Wilcoxon paired-sample test; p ϭ 0.04; n ϭ 9). Similar results were observed in GCBs as well (5.0 Ϯ 1.0 mM in control vs 2.3 Ϯ 0.5 mM in Ca 2ϩ -free; mean Ϯ SEM; n ϭ 9; two-tailed Wilcoxon paired-sample test; p ϭ 0.004). These results indicate that tonic inhibition of presynaptic PFs reported by Clomeleon imaging is due to tonic release of GABA via a mechanism that is independent of neuronal activity and does not depend entirely upon calcium influx, as has been reported previously for tonic inhibition of GCBs. These parallels between tonic inhibition of PFs and GCBs are consistent with the proposal that sustained, channel-mediated release of GABA from glia is the source of ambient GABA responsible for both forms of tonic inhibition (Lee et al., 2010) . The GABA A receptors involved in tonic inhibition of GCBs contain ␣ 6 subunits (Hamann et al., 2002) , which are preferentially blocked by low concentrations of furosemide (Wall, 2002) . To determine whether such receptors are involved in tonic inhibition of PFs, we asked whether the reduction of [Cl Ϫ ] i in PFs produced by SR was mimicked by furosemide (100 M). We found that furosemide also reduced [Cl Ϫ ] i in PFs (Fig. 5E ). The changes in [Cl Ϫ ] i produced by furosemide were very similar in magnitude to those produced by SR (Fig. 5F ) , with no significant difference between the mean changes in [Cl Ϫ ] i produced by the two drugs (two-tailed Wilcoxon paired-sample test; p ϭ 0.81; n ϭ 7). Similar results were observed for GCBs: there was no significant difference between the mean changes in [Cl Ϫ ] i produced by the two drugs (3.6 Ϯ 0.8 mM with SR vs 3.6 Ϯ 0.4 mM with furosemide; n ϭ 7; two-tailed Wilcoxon paired-sample test; p ϭ 0.94). These results indicate that that the high basal [Cl Ϫ ] i of PFs is due to the tonic activation of high-affinity GABA A receptors that contain ␣ 6 subunits. Further, we can conclude that the changes in basal [Cl Ϫ ] i produced by blockade of these GABA A receptors are due to reduction of this tonic inhibition.
Tonic inhibition of PFs in vivo
To determine whether tonic inhibition of PFs occurs in vivo, we used 2-photon imaging to measure [Cl Ϫ ] i in the intact brain of Clomeleon transgenic mice. For this purpose, a window was made in the skull of mice anesthetized by isoflurane, and Clomeleon fluorescence was imaged in granule cells in the fourth and fifth lobule or the sixth lobule of the cerebellum, near the midline (Fig. 6A) . In these conditions, we could visualize the laminar structure of the cerebellum ϳ200 m below the pial surface (Fig. 6B ). Such images were strikingly similar to what was observed in cerebellar slices in vitro ( Fig. 2A) . Unlike in slice preparations, there was no significant difference in resting [Cl Ϫ ] i between PFs and GCBs (7.5 Ϯ 2.5 mM and 10.0 Ϯ 1.7 mM, respectively; n ϭ 7; twotailed Wilcoxon paired-sample test; p ϭ 0.47). Figure 6C , D shows representative changes in [Cl Ϫ ] i in the GCBs and PFs, respectively, following subcutaneous injection of SR (5 mg/kg body weight) (Nelson et al., 2002) . In these experiments, [Cl Ϫ ] i started dropping ϳ5 min after injection of the SR solution and continued to decrease for the next 10 min or so. Presumably, the slow time course of these responses reflects the time required for SR to reach the cerebellum. Similar observations were made in a total of 4 animals.
We also applied SR (2 mM) topically onto the surface of the cerebellum in a different set of animals (n ϭ 3). To apply SR topically, a tube was placed at the edge of the craniotomy, sealed with agar and a coverslip (Fig. 6A) . The tubing was connected to a syringe pump which continuously superfused solutions during an imaging session, initially delivering normal saline as a control and then switching to SR-containing saline. Although there was again a decline in [Cl Ϫ ] i in GCBs (Fig.  6E ) and in PFs (Fig. 6F ) during treatment with SR, as observed during subcutaneous application, these decreases were preceded by an apparent increase in [Cl Ϫ ] i . The initial response was immediate and more rapid than the time required for SR to diffuse from the pial surface to the plane of focus where Clomeleon fluorescence was imaged. We suspect that this initial effect was an artifact caused by the concentrated SR solution, which was bright yellow and could differentially absorb Clomeleon emission. Considering the drops in [Cl Ϫ ] i observed with both application methods, the magnitude of this SR-induced drop in [Cl Ϫ ] i was similar in GCBs and in PFs ( Fig. 6G ; two-tailed Wilcoxon pairedsample test; p ϭ 0.94; n ϭ 7), consistent with our observations in slices (Fig. 3E) . Thus, we conclude that tonic inhibition of PFs occurs both in slices and in vivo. Our results also confirm a previous electrophysiological demonstration of tonic inhibition of GCBs in vivo (Chadderton et al., 2004) . Because these measurements were made in adult mice (age 5-10 weeks), we can conclude that tonic inhibition occurs in adult mice as well as in the younger mice used for our slice experiments.
In summary, Clomeleon imaging allowed us to monitor tonic inhibition of PFs both in vitro and in vivo. This approach revealed that tonic inhibition of PFs shares most of the properties of tonic inhibition of GCBs observed in previous electrophysiological studies.
Direct tonic inhibition of presynaptic PFs
Because tonic inhibition previously had been detected only with electrical recordings from GCBs, it is possible that tonic inhibition only occurs in the somatodendritic region of these cells. In this case, the decrease in [Cl Ϫ ] i of PFs produced by application of SR (Figs. 3, 5 , and 6) would be an indirect consequence of blocking tonic inhibition in the somata and dendrites of granule cells, with Cl Ϫ diffusing from PFs to the rest of the granule cell (Fig. 7A,  left) . Alternatively, the drop in PF [Cl Ϫ ] i could result directly from tonic inhibition of PFs (Fig. 7A, right) To distinguish between these two possibilities, we locally applied SR in cerebellar slices. Local application of SR onto GCBs caused a localized decrease in [Cl Ϫ ] i (Fig. 7B) , with the mean decrease in [Cl Ϫ ] i in GCBs being 1.9 Ϯ 0.4 mM (mean Ϯ SEM; n ϭ 7). This response was transient and recovered soon after the 10-s-long application of SR ended (Fig. 7C) , presumably due to rapid diffusion of the drug. This result is predicted by both of the models shown in Figure 7A and serves as a positive control to indicate that local SR application is effective in blocking tonic inhibition. To distinguish between the two models, we next locally applied SR onto PFs. This caused a transient decrease in [Cl Ϫ ] i in PFs (Fig. 7 D, E) . The mean decrease in [Cl Ϫ ] i in PFs was 2.0 Ϯ 0.3 mM (mean Ϯ SEM; n ϭ 7). This result is consistent with the model shown in Figure 7A (right) and therefore indicates a tonic inhibition of PFs via sustained activation of GABA A receptors that reside on PFs.
Biphasic GABA actions on PFs
Although our results with GABA A receptor antagonists indicate that GABA tonically inhibits PFs, local application of GABA or GABA A agonists reportedly excites PFs (Stell et al., 2007; Stell, 2011; Astorga et al., 2015) . To reconcile these seemingly contradictory results, we locally applied GABA (1 mM) onto PFs. Local application of GABA onto PFs decreased [Cl Ϫ ] i (Fig. 8 A, B) . These responses to GABA were reduced significantly by SR (100 M; from 0.73 Ϯ 0.14 mM to 0.10 Ϯ 0.05 mM; mean Ϯ SEM; n ϭ 11; two-tailed Wilcoxon paired-sample test; p ϭ 0.001), but not by a GABA B antagonist, CGP55845 (2-50 M; from 2.5 Ϯ 0.7 mM to 2.5 Ϯ 0.6 mM; mean Ϯ SEM; n ϭ 7; two-tailed Wilcoxon paired-sample test; p ϭ 0.38). This indicates that the GABAinduced decrease in [Cl Ϫ ] i is mediated solely by GABA A receptors. This decrease in [Cl Ϫ ] i must result from an efflux of Cl Ϫ that would depolarize the PF membrane potential, indicating that GABA is excitatory under these conditions. This confirms previous conclusions (Stell et al., 2007; Stell, 2011; Astorga et al., 2015) .
In contrast, local application of GABA onto GCBs increased [Cl Ϫ ] i ( Fig. 8C,D ; 0.7 Ϯ 0.2 mM; mean Ϯ SEM; n ϭ 10), indicating an inhibitory action of GABA on this compartment of the granule cell. Further, these results indicate limited diffusion of Cl Ϫ between the PFs and GCBs. The concentration of ambient GABA that produces tonic inhibition has been estimated to be ϳ160 nM (Santhakumar et al., 2006; Lee et al., 2010) , which is much lower than the concentration produced by local GABA application (1 mM in our experiments (Fig. 9A) . This is consistent with the observed reduction in [Cl Ϫ ] i caused by SR blockade of tonic inhibition (Fig. 3) . Higher concentrations of GABA caused larger increases in [Cl Ϫ ] i , with maximal effects observed at 1 M GABA (Fig. 9B,C) ; 10 M GABA caused an increase in [Cl Ϫ ] i in PFs similar to that produced by 1 M GABA (Fig. 9C) . However, 100 M GABA produced a smaller increase than that produced by lower concentrations of GABA; in some cases, 100 M GABA caused a small net decrease in [Cl Ϫ ] i (Fig. 9D) , revealing biphasic effects of GABA on PFs ( Fig. 9E; n ϭ 8 ). This biphasic property accounts for the decreases in [Cl Ϫ ] i observed both when blocking tonic inhibition of PFs (Fig. 3) and when locally applying 1 mM GABA onto PFs (Fig. 8) . In contrast, increasing GABA concentrations produced only monotonic rises in [Cl Ϫ ] i in GCBs ( Fig. 9F ; n ϭ 8).
The dose-response curve for GCBs was well fit by the Hill equation (Fig. 9F, curve) , with a Hill coefficient of 0.66 and a K d of 160 nM (n ϭ 8). A similar relationship could also describe the responses of PFs to GABA concentrations of Յ10 (Quirk et al., 1994; Saxena and Macdonald, 1996; Rossi and Hamann, 1998) .
The two processes underlying the biphasic response of PFs to GABA could be dissociated by treatment with furosemide (100 M). This drug completely prevented GABA from elevating [Cl Ϫ ] i in PFs ( Fig. 9E ; n ϭ 7). This blockage of GABA responses was statistically significant (two-way ANOVA; the main effect of furosemide: F (1,78) ϭ 46.1, p Ͻ 0.05; the main effect of GABA: F (1,78) ϭ 2.38, p Ͻ 0.05; their interactions: F (5,78) ϭ 2.36, p Ͻ 0.05; in Dunnett's pairwise comparison, all the furosemide conditions were significantly different from control, p Ͻ 0.05 and control responses to 1 and 10 M GABA were significantly different from 0, p Ͻ 0.05). The same was true in GCBs ( Fig. 9F ; n ϭ 7; two-way ANOVA; the main effect of furosemide: F (1,78) ϭ 52.9, p Ͻ 0.05; the main effect of GABA: F (1,78) ϭ 5.01, p Ͻ 0.05; their interactions: F (5,78) ϭ 3.21, p Ͻ 0.05; in Dunnett's pairwise comparison, all the furosemide conditions were significantly different from control, p Ͻ 0.05 and control responses to 1, 10, and 100 M GABA were significantly different from 0, p Ͻ 0.05). This suggests that exogenous GABA raises [Cl Ϫ ] i by activating high-affinity GABA A receptors that contain ␣ 6 subunits (Wall, 2002) . In contrast, the reduction of [Cl Ϫ ] i produced in PFs by higher doses of GABA was not blocked by furosemide (Fig.  9E) , including when 1 mM GABA was locally applied onto PFs with the procedure illustrated in Figure 8 (data not shown). These results indicate that the ability of high concentrations of GABA to cause Cl Ϫ efflux is due to a different population of GABA A receptors with a very low affinity for GABA. This affinity must be Ͼ100 M because at this concentration the dose-response curve measured in the presence of furosemide shows no sign of saturation (Fig. 9E) . This is consistent with previous work showing that phasic inhibition of granule cells is mediated by low-affinity synaptic GABA A receptors that are insensitive to furosemide (Rossi and Hamann, 1998; Hamann et al., 2002) .
Anion fluxes underlying GABA inhibition and excitation of PFs
How can different concentrations of GABA cause Cl Ϫ to flow in opposite directions? The efflux of Cl Ϫ during the action of high [GABA] indicates that the PF membrane potential is more negative than E Cl (Ϫ65 mV for PFs). This arises from the high resting [Cl Ϫ ] i of PFs (Fig. 2C,D) , as well as the likely contribution of a relatively high resting K ϩ conductance to maintain a hyperpolarized resting membrane potential. However, the action of low [GABA] to create a sustained influx of Cl Ϫ requires an additional depolarizing drive to maintain the membrane potential at a level more positive than E Cl ; otherwise, the resting membrane potential would quickly hyperpolarize to E Cl and Cl Ϫ influx would cease. It is known that sustained activation of GABA A receptors can depolarize neurons because efflux of HCO 3 Ϫ through GABA receptors occurs even when the electrochemical gradient for Cl Ϫ has collapsed (Staley et al., 1995; Staley and Proctor, 1999; Ferrini et al., 2013) . We therefore next considered the possible role of HCO 3 Ϫ in maintaining the driving force for Cl Ϫ influx during tonic inhibition. The contribution of HCO 3 Ϫ to tonic inhibition was examined by measuring Cl Ϫ fluxes while removing HCO 3 Ϫ . To eliminate HCO 3 Ϫ , NaHCO 3 in the extracellular solution was replaced by HEPES and CO 2 was replaced with O 2 ; extracellular pH was maintained at 7.4. In addition, intracellular generation of HCO 3 Ϫ by carbonyl anhydrase was blocked by the inhibitor acetazolamide (50 M) (Kim and Trussell, 2009; Ferrini et al., 2013) . Such depletion of intracellular HCO 3 Ϫ could be observed as an alkalization of cytoplasmic pH in PFs (Fig. 10 A, B) . This effect upon presynaptic pH was statistically significant (n ϭ 3; one-way ANOVA; F (2,6) ϭ 12.8; p ϭ 0.007; followed by Dunnett's test; q(6, 3) ϭ 3.33; p ϭ 0.028). Removal of HCO 3 Ϫ also reduced resting [Cl Ϫ ] i significantly ( Fig. 10C,D ; n ϭ 7; one-way ANOVA; F (2,18) ϭ 13.7; p ϭ 0.0002; followed by Dunnett's test; q(18, 3) ϭ 4.31; p ϭ 0.0008). This effect perhaps was due to the predicted reduction in driving force for Cl Ϫ influx during tonic inhibition. More importantly, the absence of HCO 3 Ϫ caused a complete loss of the drop in [Cl Ϫ ] i caused by SR blockade of tonic inhibition (Fig.  10E) ; this effect was statistically significant (n ϭ 4; p Ͻ 0.05; one-way ANOVA followed by Dunnett's test). Further, this effect on SR responses reversed when HCO 3 Ϫ was restored, indicating that it is not a nonspecific effect associated with HCO 3 Ϫ removal. Together, these results indicate that HCO 3 Ϫ is required to sustain the driving force for Cl Ϫ influx during tonic inhibition. In conclusion, PFs possess at least two types of GABA A receptors (Fig. 11) . One type of GABA A receptor has a high affinity for GABA and is tonically activated by ambient GABA, yielding an influx of Cl Ϫ that produces tonic inhibition (Fig. 11,  left) . HCO 3 Ϫ permeation in these receptors apparently is significant and required to sustain tonic inhibition by providing the driving force for Cl Ϫ influx. These receptors are blocked by furosemide (Figs.  5 E, F, 9E) . The second type of GABA A receptor has a low affinity for GABA (Fig.  11, right) . Activation of this receptor by high concentrations of GABA (Ն50 M) causes Cl Ϫ efflux that can depolarize PFs, evident as both an enhancement of PF transmission (Stell et al., 2007; Pugh and Jahr, 2011; Dellal et al., 2012; Astorga et al., 2015) and a decline in [Cl Ϫ ] i (Figs. 8B,  9D ). These receptors are not blocked by furosemide (Fig. 9E ) and apparently are not permeable to HCO; the driving force for Cl Ϫ efflux through these receptors is provided by a hyperpolarized resting membrane potential, due to resting K ϩ efflux, as well as possible desensitization of the high-affinity, HCO 3 Ϫ /CI Ϫ permeable GABA receptors.
Regulation of glutamate release by presynaptic tonic inhibition
Tonic inhibition of presynaptic PFs by ambient GABA could also regulate the amount of transmitter released from PF terminals, thereby influencing phasic synaptic transmission between granule cells and postsynaptic Purkinje cells. To examine this possibility, we used SR application to block tonic inhibition while measuring EPSCs produced in Purkinje cells in response to glutamate released by PFs. In these experiments, we held the Purkinje cells at E Cl to avoid possible complications caused by SR blocking IPSCs generated in Purkinje cells by phasic release of GABA from interneurons (Konnerth et al., 1990; Llano et al., 1991; Vincent and Marty, 1996; Kim et al., 2014) . These experiments were done in sagittal slices; in such slices, PFs are severed from GCBs during the slicing procedure, thereby eliminating any possible contribution of GCBs to measured synaptic responses.
We first examined the effect of SR on spontaneous release of glutamate from PF terminals. Small spontaneous inward currents could be detected in Purkinje cells (Fig. 12A) . Treatment with the glutamate receptor antagonist, kynurenic acid (3 mM), reduced the frequency of these currents by 99%, from 5.4 Ϯ 1.4 Hz to 0.1 Ϯ 0.1 Hz (mean Ϯ SEM; n ϭ 6 cells). This indicates that these currents represent glutamatergic EPSCs that were virtually uncontaminated by GABAergic IPSCs and presumably reflect spontaneous miniature EPSCs (Bordey and Sontheimer, 2003). Blockade of tonic inhibition, by application of SR, caused the frequency of these spontaneous EPSCs to increase (Fig. 12A ).
This effect of SR treatment was relatively rapid, reaching a peak within 1-2 min after beginning SR superfusion (Fig. 12B) . This approximately parallels the time course of changes in [Cl Ϫ ] i caused in PFs by SR (Fig. 3C) . SR increased the mean frequency of spontaneous EPSCs by 172 Ϯ 70% (mean Ϯ SEM; n ϭ 6 cells) over the values measured before SR treatment (Fig. 12C ). This increase in EPSC frequency was significant (two-tailed Wilcoxon paired-sample test; p ϭ 0.03; n ϭ 6 cells). In contrast, SR had no effect on the distribution of spontaneous EPSC amplitudes ( Fig.  12D ; Kolmogorov-Smirnov test; D ϭ 0.014; p ϭ 0.13; n [weighted number of elements] ϭ 7,072) or the mean amplitude of spontaneous EPSCs ( Fig. 12E ; two-tailed Wilcoxon pairedsample test; p ϭ 0.56; n ϭ 6 cells), indicating a lack of effect of SR treatment on the properties of postsynaptic Purkinje cells (Fatt and Katz, 1952) . Thus, spontaneous release of glutamate from presynaptic PFs is limited by tonic inhibition. We next examined the effect of SR on EPSCs evoked by PF stimulation. In these experiments, an extracellular stimulating electrode was used to activate presynaptic PFs and was placed near the Purkinje cell body to minimize possible shunting of the evoked EPSCs along Purkinje cell dendrites by GABAergic inhibition. The inward currents evoked by such stimuli were almost completely blocked by the combined application of the glutamate antagonists kinurenic acid (3 mM) and CNQX (100 M; Fig. 13A ; n ϭ 10), indicating that these currents were almost purely glutamatergic EPSCs.
SR treatment increased the amplitude of these evoked EPSCs (Fig. 13A) . The effect of SR on EPSC amplitude was reversible (Fig. 13 B, C) . On average, SR treatment increased EPSC amplitude by 16 Ϯ 8% (mean Ϯ SEM; n ϭ 9; Fig. 13C ), and this effect was statistically significant (two-tailed Wilcoxon paired-sample test; p ϭ 0.037). These results indicate that tonic inhibition suppresses phasic transmission between presynaptic PFs and postsynaptic Purkinje cells. Given the results above indicating that SR does not alter the amplitude of spontaneous EPSCs (Fig. 12 D, E) , we conclude that this effect of SR on EPSC amplitude is due to tonic inhibition reducing the amount of glutamate released from presynaptic PFs in response to action potentials (Del Castillo and Katz, 1954) .
To provide further support for our conclusion that SR affects phasic synaptic transmission by acting on presynaptic PFs, we next examined the effects of SR on synaptic facilitation. Given that facilitation is very sensitive to the probability of transmitter release, changes in transmitter release from presynaptic terminals usually alter the degree of facilitation (Dobrunz and Stevens, 1997; Oleskevich et al., 2000) . Under control conditions, EPSCs facilitated when pairs of PF stimuli were applied at an interval of 100 ms, as has been described previously (Konnerth et al., 1990; Atluri and Regehr, 1996; Kreitzer and Regehr, 2000) . Application of SR caused the second EPSC to show less facilitation than in control conditions. This effect on synaptic facilitation was readily observed after normalizing the amplitudes of EPSCs produced by the first stimuli (Fig.  13D) . The effect of SR on facilitation was reversible and statistically significant ( Fig. 13E ; two-tailed Wilcoxon paired-sample test; p ϭ 0.02; n ϭ 9). This reduction in facilitation provides a second indication that tonic inhibition normally acts to decrease the probability of glutamate release from presynaptic terminals of PFs in response to action potentials.
Finally, we examined a third index of presynaptic function, EPSC coefficient of variation (CV) (Del Castillo and Katz, 1954; Silver et al., 1996; Silver et al., 1998; Sola et al., 2004) . This parameter also was reversibly reduced by SR, and the effect of SR on the coefficient of variation was statistically significant ( Fig. 13F ; two-tailed Wilcoxon paired-sample test; p ϭ 0.002; n ϭ 10). The decrease in the CV produced by SR is a third independent indication that tonic inhibition reduces the probability of glutamate release from presynaptic PFs in response to action potentials.
In conclusion, tonic inhibition reduces both spontaneous and evoked release of glutamate from PFs and thereby limits phasic synaptic transmission between PFs and Purkinje cells.
Discussion
We used Clomeleon imaging to detect tonic inhibition of cerebellar granule cells. Tonic inhibition was not limited to GCBs and dendrites: granule cell axons, the PFs, also have tonically activated GABA A receptors. The properties of PF tonic inhibition are much like those of tonic inhibition of GCBs, with the important additional property of regulating neurotransmitter release from PF presynaptic terminals.
Optogenetic imaging of tonic inhibition
Optogenetic techniques are revolutionizing our ability to both control and monitor neuronal activity, as well as to map neural circuits (Baker et al., 2008; Berglund et al., 2008; Mancuso et al., 2011; Deisseroth, 2015) . Here we have used the optogenetic indicator, Clomeleon , to monitor tonic inhibition. Transgenic mice that express Clomeleon in cerebellar granule cells allowed us to visualize tonic inhibition of these cells, both in vitro and in vivo. This approach revealed that tonic inhibition occurs in PFs, a location that has gone undetected in previous electrophysiological studies. Thus, Clomeleon imaging provides a means of detecting tonic inhibition offering technical ease, spatial resolution, and targeting to genetically defined neuronal populations. This approach should greatly promote efforts to identify the locations and physiological significance of tonic inhibition throughout the brain, as well as to understand the underlying mechanisms.
Presynaptic GABA A receptors Presynaptic inhibition of phasic synaptic transmission by GABA A receptors was first identified in the crayfish neuromuscular junction (Dudel and Kuffler, 1961) and subsequently has been found in many types of synapses in the mammalian CNS (for review, see Trigo et al., 2008) . Our work adds cerebellar PFs to the list of presynaptic terminals that evince inhibition mediated by GABA A receptors. Thus, GABA A receptors join adenosine and GABA B receptors (Dittman and Regehr, 1996, 1997) as presynaptic modulators of excitatory transmission in the cerebellar ML.
Following blockade of tonic inhibition, we observed a substantial increase in spontaneous excitatory synaptic transmission between granule cells and Purkinje cells (Fig. 12) and a smaller but significant enhancement of evoked excitatory transmission (Fig. 13) . These experiments were made in sagittal slices, where the vast majority of granule-cell axons (PFs) were severed from their cell bodies in the granular layer, thus eliminating any contribution of granule-cell dendrites and cell bodies to the response to SR application. Still, SR can block GABA A receptors on Purkinje cell dendrites, and this could affect propagation of synaptic current along the dendrites via shunting inhibition, potentially contributing to changes in EPSCs recorded in the cell body. However, this cannot explain our results because there was no observable change in the amplitude of spontaneous EPSCs during SR treatment (Fig. 12 D, E) . Further, we also observed changes in synaptic facilitation and coefficient of variance, measures that solely depend upon presynaptic properties. Together, we can conclude that tonic inhibition reduces both spontaneous and evoked release of glutamate from PFs.
The magnitude of the effect of presynaptic tonic inhibition on PF synaptic transmission (ϳ16%) was smaller than some other forms of synaptic plasticity found at this synapse: long-term potentiation can strengthen PF synapses on Purkinje cells by up to 75% (Hirano, 1990) , and long-term depression can reduce transmission at these synapses by as much as 50% (Tanaka et al., 2007) . However, given that ϳ150 PF synapses must be active to fire an action potential in a Purkinje cell (Isope and Barbour, 2002) , a 16% inhibition of PF synaptic transmission will negate the effect of Ͼ20 PF inputs to a Purkinje cell. This would be expected to significantly alter integration of PF inputs by Purkinje cells. The substantial effects of tonic inhibition on synaptic facilitation (Fig.  13E ) and synaptic variability (Fig. 13F ) would be expected to have further dynamic effects on integration of PF synaptic input.
Our conclusion that presynaptic GABA A receptors control phasic synaptic transmission between cerebellar granule cells and Purkinje cells is consistent with previous results. Immunoelectron microscopy studies have identified GABA A receptors on PF terminals (Stell et al., 2007) . In cerebellar granule cells, single electrical stimuli can generate repetitive firing of action potentials that is blocked by muscimol, a GABA A agonist (Isope et al., 2004) . Further, both spontaneous and evoked glutamate release from PFs is regulated by activation of GABA A receptors (Stell et al., 2007; Stell, 2011; Astorga et al., 2015) .
One apparent discrepancy is that application of GABA A agonists enhances glutamate release from PFs (Stell et al., 2007) , although we have found that ambient GABA is inhibitory. We have demonstrated that this difference is due to the GABA concentrations present in the two conditions. Specifically, during tonic inhibition, ambient GABA concentrations are in the submicromolar range (Santhakumar et al., 2006) , a concentration where GABA increases [Cl Ϫ ] i in PFs (Fig. 9F ) . In contrast, the excitatory actions of GABA on PFs require high GABA concentrations. Thus, in addition to its tonic inhibitory action, high concentrations of GABA (50 M to 1 mM) cause a Cl Ϫ efflux (Figs. 8, 9 ) that depolarizes PFs (Astorga et al., 2015) , accounting for the observation that activation of GABA A receptors by such concentrations of GABA can augment glutamate release (Stell et al., 2007) . The timing of GABA application also appears to be important for inhibitory action of GABA. Stell (2011) reported that the effect of the GABA A agonist, muscimol, on action potential firing of PFs became inhibitory when application was prolonged, consistent with our observation that the sustained presence of ambient GABA is inhibitory.
Manipulation of HCO 3 Ϫ showed that this anion enables a sustained influx of Cl Ϫ during tonic inhibition (Fig. 10) . Although HCO 3 Ϫ supports tonic inhibition, such an effect would prevent Cl Ϫ efflux during the excitatory action of GABA. We thus hypothesize that differences in HCO 3 Ϫ permeability between the high-and low-affinity GABA A receptors of PFs underlies the biphasic nature of GABA action (Figs. 8-10 ). Differences have been observed in the HCO 3 Ϫ permeability of GABA receptors (Farrant and Kaila, 2007; Alvarez-Leefmans and Delpire, 2009 ), and such a differential permeability to HCO 3 Ϫ presumably is conferred by GABA A receptors with different subunit composition. Future studies will be needed to identify the molecular determinants of HCO 3 Ϫ permeability in the GABA A receptors of PFs. The receptors involved in the excitatory presynaptic action of high concentrations of GABA are not blocked by furosemide and therefore are distinct from those that mediate tonic presynaptic inhibition. Although the subunit composition of these receptors also remains to be elucidated, the immunoelectron microscopy data of Stell et al. (2007) indicate that these receptors contain at least the GABA A receptor ␣ 1 subunit.
Regulation of phasic transmission by tonic inhibition
In addition to conventional synaptic transmission that relies on presynaptic action potentials to trigger phasic, Ca 2ϩ -dependent exocytosis of neurotransmitters, a second mode of communication is based on tonic release of neurotransmitters (most notably GABA) via a mechanism that depends on neither neuronal activity nor Ca 2ϩ -dependent exocytosis (Jabaudon et al., 1999; Liu et al., 2000; Rossi et al., 2003) and may be due to channel-mediated release of GABA from glia (Lee et al., 2010) . We have discovered that these two mechanisms of synaptic signaling interact, specifically that GABA-mediated tonic inhibition limits phasic glutamate release from PFs. Thus, the low concentrations of ambient GABA present under physiological conditions allows tonic inhibition to fine-tune synaptic circuitry mediated by phasic synaptic transmission.
The logic behind regulation of phasic transmission by tonic inhibition is not yet clear. In general, tonic inhibition is thought to be an adaptive mechanism that alters the input-output gain of a neuron and the excitability of neural networks. Tonic inhibition of phasic synaptic transmission should provide another means of setting the overall tone of a synaptic network. Because the ambient GABA that causes tonic inhibition of PFs appears to be spatially diffuse, this cross talk could provide a spatially diffuse mechanism for controlling neural circuits constructed from phasic synapses. Presynaptic tonic inhibition potentially can also make synaptic information processing sensitive both to changes in ambient GABA signaling as well as to various types of regulators of GABA A receptors. Tonic inhibition shows distinct cell specificity and developmental profiles in different brain regions (Semyanov et al., 2004) . Tonic inhibition also is regulated by a variety of endogenous and exogenous factors that might provide fine control of phasic synaptic signaling (Stell et al., 2003; Maguire and Mody, 2007) and conceivably could regulate tonic inhibition of presynaptic PFs as well.
In conclusion, we have used the optogenetic indicator, Clomeleon, to visualize tonic inhibition in the cerebellum. Our finding of tonic inhibition of presynaptic PFs indicates that the ambient GABA level is high enough to activate GABA A receptors throughout the cerebellar cortex, including PFs within the ML. This was observed both in slices and in vivo, indicating that this level of ambient GABA is physiologically relevant. We have found that PF synaptic transmission is under the control of tonic inhibition. Our identification of this novel interaction between phasic and tonic signaling mechanisms suggests that tonic inhibition probably plays a larger than expected role in regulating cerebellar function and perhaps the function of circuits in other brain regions as well.
